A role for anti-BP180 autoantibodies in chronic rhinosinusitis

Jill S. Jeffe, Sudarshan Seshadri, Kevin J. Hamill, Julia He Huang, Roderick Carter, Lydia Suh, Kathryn E. Hulse, James Norton, David B. Conley, Rakesh K. Chandra, Robert C. Kern, Jonathan C.R. Jones, Robert P. Schleimer, Bruce K. Tan*

*Corresponding author for this work

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Objectives/Hypothesis Chronic Rhinosinusitis (CRS) is accompanied by evidence of a vigorous adaptive immune response, and emerging studies demonstrate that some nasal polyps manifest a polyclonal autoantibody response. We previously found that antibodies against BP180, a component of the hemidesmosome complex and the dominant epitope in autoimmune bullous pemphigoid, were found at elevated levels in nasal polyp tissue. Given the critical role of hemidesmosomes in maintaining epithelial integrity, we sought to investigate the distribution of BP180 in nasal tissue and evaluate for evidence of systemic autoimmunity against this antigen in CRS. Study Design Case-control experimental study. Methods The expression and distribution of BP180 in cultured nasal epithelial cells and normal nasal tissue were confirmed using real-time polymerase chain reaction (PCR), Western immunoblotting, immunofluorescence and immunohistochemistry. Sera were collected from three groups: control, CRSsNP, and CRSwNP. A commercially available ELISA was utilized to compare anti-BP180 autoantibody levels in sera. Results BP180 is expressed in nasal epithelium, but is not confined to the basement membrane as it is in human skin. In cultured nasal epithelial cells, confocal immunofluorescence showed a punctate distribution of BP180 along the basal surface, consistent with its distribution in epithelial keratinocytes. There are significantly higher levels of circulating nonpathologic anti-BP180 autoantibodies in CRS patients compared with normal controls (P <0.05). Conclusions BP180 is more widely expressed in nasal epithelium versus skin, although it appears to play a similar role in the formation of hemidesmosomes along the basement membrane. Further investigations are ongoing to characterize the pathogenicity of the anti-epithelial antibody response in CRS.

Original languageEnglish (US)
Pages (from-to)2104-2111
Number of pages8
JournalLaryngoscope
Volume123
Issue number9
DOIs
StatePublished - Sep 1 2013

Keywords

  • Chronic rhinosinusitis
  • autoantibodies
  • autoimmunity
  • bullous pemphigoid
  • nasal polyps
  • sinusitis

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'A role for anti-BP180 autoantibodies in chronic rhinosinusitis'. Together they form a unique fingerprint.

  • Cite this

    Jeffe, J. S., Seshadri, S., Hamill, K. J., Huang, J. H., Carter, R., Suh, L., Hulse, K. E., Norton, J., Conley, D. B., Chandra, R. K., Kern, R. C., Jones, J. C. R., Schleimer, R. P., & Tan, B. K. (2013). A role for anti-BP180 autoantibodies in chronic rhinosinusitis. Laryngoscope, 123(9), 2104-2111. https://doi.org/10.1002/lary.24016